Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Modern Rheumatology
Published in: Modern Rheumatology 1/2008

01-02-2008 | Case Report

A case of pulmonary asbestosis presenting with temporal arteritis involving multiple medium-sized vessels

Authors: Shintaro Hirata, Noboru Hattori, Nobuhisa Ishikawa, Kazunori Fujitaka, Kazuhiko Kumagai, Yasuyuki Taooka, Yoshinori Haruta, Akihito Yokoyama, Nobuoki Kohno

Published in: Modern Rheumatology | Issue 1/2008

Login to get access

Abstract

A 76-year-old woman with pulmonary asbestosis was admitted with fever and polymyalgia. She subsequently developed a visual disorder, hemoptysis, and hemoperitoneum. A biopsy of the temporal artery revealed the presence of giant-cell arteritis. CT and angiography showed hemorrhaging from the bronchial and abdominal arteries. These observations suggested temporal arteritis in which medium-sized vessels were involved. This case implies the association between vasculitis and asbestosis, and suggests a problem in the classification of vasculitides.
Literature
1.
Noonan CW, Pfau JC, Larson TC, Spence MR. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect. 2006;114:1243–7.PubMedCrossRef
2.
Bartunkova J, Pelclova D, Fenclova Z, Sediva A, Lebedova J, Tesar V, et al. Exposure to silica and risk of ANCA-associated vasculitis. Am J Ind Med. 2006;49:569–76.PubMedCrossRef
3.
Beaudreuil S, Lasfargues G, Laueriere L, El Ghoul Z, Fourquet F, Longuet C, et al. Occupational exposure in ANCA-positive patients: a case-control study. Kidney Int. 2005;67:1961–6.PubMedCrossRef
4.
Lane SE, Watts RA, Bentham G, Innes NJ, Scott DG. Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis Rheum. 2003;48:814–23.PubMedCrossRef
5.
Stratta P, Messuerotti A, Canavese C, Coen M, Luccoli L, Bussolati B, et al. The role of metals in autoimmune vasculitis: epidemiological and pathogenic study. Sci Total Environ. 2001;270:179–90.PubMedCrossRef
6.
Tervaert JW, Stegeman CA, Kallenberg CG. Silicon exposure and vasculitis. Curr Opin Rheumatol. 1998;10:12–7.PubMedCrossRef
7.
Rihova Z, Maixnerova D, Jancova E, Pelclova D, Bartunkova J, Fenclova Z, et al. Silica and asbestos exposure in ANCA-associated vasculitis with pulmonary involvement. Ren Fail. 2005;27:605–8.PubMedCrossRef
8.
Philteos GS, Coverett K, Chibbar R, Ward HA, Cockcroft DW. Asbestosis and probable microscopic polyangiitis. Can Respir J. 2004;11:359–62.PubMed
9.
Pelclova D, Bartunkova J, Fenclova Z, Lebedova J, Hladikova M, Benakova H. Asbestos exposure and antineutrophil cytoplasmic antibody (ANCA) positivity. Arch Environ Health. 2003;58:662–8.PubMedCrossRef
10.
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.PubMedCrossRef
11.
12.
13.
Turner-Warwick M, Parkes WR. Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J. 1970;3:492–5.PubMedCrossRef
14.
Inoue T, Tanaka E, Kato T, Sakuramoto M, Minakuchi M, Maeda Y, et al. A case of MPO-ANCA-related vasculitis after asbestos exposure with progression of a renal lesion after improvement of interstitial pneumonia. Nihon Kokyuki Gakkai Zasshi. 2004;42:496–501.PubMed
15.
Wu P, Hyodoh F, Hatayama T, Sakaguchi H, Hatada S, Miura Y, et al. Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A. Immunol Lett. 2005;98:145–52.PubMedCrossRef
16.
Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant-cell arteritis. Arthritis Rheum. 1990;33:1122–8.PubMedCrossRef
17.
Hamidou MA, Moreau A, Toquet C, El Kouri D, de Faucal P, Grolleau JY. Temporal arteritis associated with systemic necrotizing vasculitis. J Rheumatol. 2003;30:2165–9.PubMed
18.
Esteban MJ, Font C, Hernandez-Rodriguez J, Valls-Sole J, Sanmarti R, Cardellach F, et al. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients. Arthritis Rheum. 2001;44:1387–95.PubMedCrossRef
19.
Genereau T, Lortholary O, Pottier MA, Michon-Pasturel U, Ponge T, de Wazieres B, et al. Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study Group. Arthritis Rheum. 1999;42:2674–81.PubMedCrossRef
20.
Glover MU, Muniz J, Bessone L, Carta M, Casellas J, Maniscalco BS. Pulmonary artery obstruction due to giant-cell arteritis. Chest 1987;91:924–5.PubMedCrossRef
Metadata
Title
A case of pulmonary asbestosis presenting with temporal arteritis involving multiple medium-sized vessels
Authors
Shintaro Hirata
Noboru Hattori
Nobuhisa Ishikawa
Kazunori Fujitaka
Kazuhiko Kumagai
Yasuyuki Taooka
Yoshinori Haruta
Akihito Yokoyama
Nobuoki Kohno
Publication date
01-02-2008
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 1/2008
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-007-0016-x

Other articles of this Issue 1/2008

Modern Rheumatology 1/2008 Go to the issue

Case Report

A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine

Case Report

Spontaneous pneumothorax in Wegener's granulomatosis: a case report

Case Report

Severe airflow limitation in two patients with systemic lupus erythematosus: effect of inhalation of anticholinergics

Case Report

Polymyalgia rheumatica as the manifestation of unclassified aortitis

Original Article

No changes in infliximab levels in blood stored for preoperative autologous blood donation

Case Report

Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits